Search research articles
Contact Us
Filters
Showing results (11-20 of 33) with videos related to
Page
of 4
Sort By:
Human Vaccines & Immunotherapeutics
|
December 20, 2012
Immunogenicity in mice and non-human primates of the Group A Streptococcal J8 peptide vaccine candidate conjugated to CRM197
Ivette Caro-Aguilar, Elizabeth Ottinger, Robert W Hepler, et al.
Journal of the American Chemical Society
|
August 23, 2007
Fully synthetic carbohydrate HIV antigens designed on the logic of the 2G12 antibody
Isaac J Krauss, Joseph G Joyce, Adam C Finnefrock, et al.
The Journal of Biological Chemistry
|
September 19, 2002
Enhancement of alpha -helicity in the HIV-1 inhibitory peptide DP178 leads to an increased affinity for human monoclonal antibody 2F5 but does not elicit neutralizing responses in vitro. Implications for vaccine design
Joseph G Joyce, William M Hurni, Michael J Bogusky, et al.
Frontiers in Immunology
|
October 16, 2018
A Comprehensive Analysis of the T and B Lymphocytes Repertoire Shaped by HIV Vaccines
Longlong Wang, Wei Zhang, Liya Lin, et al.
Frontiers in Immunology
|
December 28, 2018
Corrigendum: A Comprehensive Analysis of the T and B Lymphocytes Repertoire Shaped by HIV Vaccines
Longlong Wang, Wei Zhang, Liya Lin, et al.
Biochemistry
|
December 21, 2006
Solution state characterization of amyloid beta-derived diffusible ligands
Robert W Hepler, Karen M Grimm, Deborah D Nahas, et al.
Virology
|
December 17, 2008
Characterizations of four monoclonal antibodies against M2 protein ectodomain of influenza A virus
Tong-Ming Fu, Daniel C Freed, Melanie S Horton, et al.
Protein Science : a Publication of the Protein Society
|
August 26, 2018
Spectroscopic analysis of chlamydial major outer membrane protein in support of structure elucidation
Robert W Hepler, Debbie D Nahas, Bob Lucas, et al.
Current HIV Research
|
April 14, 2004
Progress towards the development of a HIV-1 gp41-directed vaccine
Georgia B McGaughey, Gaetano Barbato, Elisabetta Bianchi, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 20, 2024
Stabilized trimeric peptide immunogens of the complete HIV-1 gp41 N-heptad repeat and their use as HIV-1 vaccine candidates
Chengwei Wu, Izzat T Raheem, Debbie D Nahas, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 33) with videos related to
Sort By:
Page
of 4
Human Vaccines & Immunotherapeutics
|
December 20, 2012
Immunogenicity in mice and non-human primates of the Group A Streptococcal J8 peptide vaccine candidate conjugated to CRM197
Ivette Caro-Aguilar, Elizabeth Ottinger, Robert W Hepler, et al.
Journal of the American Chemical Society
|
August 23, 2007
Fully synthetic carbohydrate HIV antigens designed on the logic of the 2G12 antibody
Isaac J Krauss, Joseph G Joyce, Adam C Finnefrock, et al.
The Journal of Biological Chemistry
|
September 19, 2002
Enhancement of alpha -helicity in the HIV-1 inhibitory peptide DP178 leads to an increased affinity for human monoclonal antibody 2F5 but does not elicit neutralizing responses in vitro. Implications for vaccine design
Joseph G Joyce, William M Hurni, Michael J Bogusky, et al.
Frontiers in Immunology
|
October 16, 2018
A Comprehensive Analysis of the T and B Lymphocytes Repertoire Shaped by HIV Vaccines
Longlong Wang, Wei Zhang, Liya Lin, et al.
Frontiers in Immunology
|
December 28, 2018
Corrigendum: A Comprehensive Analysis of the T and B Lymphocytes Repertoire Shaped by HIV Vaccines
Longlong Wang, Wei Zhang, Liya Lin, et al.
Biochemistry
|
December 21, 2006
Solution state characterization of amyloid beta-derived diffusible ligands
Robert W Hepler, Karen M Grimm, Deborah D Nahas, et al.
Virology
|
December 17, 2008
Characterizations of four monoclonal antibodies against M2 protein ectodomain of influenza A virus
Tong-Ming Fu, Daniel C Freed, Melanie S Horton, et al.
Protein Science : a Publication of the Protein Society
|
August 26, 2018
Spectroscopic analysis of chlamydial major outer membrane protein in support of structure elucidation
Robert W Hepler, Debbie D Nahas, Bob Lucas, et al.
Current HIV Research
|
April 14, 2004
Progress towards the development of a HIV-1 gp41-directed vaccine
Georgia B McGaughey, Gaetano Barbato, Elisabetta Bianchi, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 20, 2024
Stabilized trimeric peptide immunogens of the complete HIV-1 gp41 N-heptad repeat and their use as HIV-1 vaccine candidates
Chengwei Wu, Izzat T Raheem, Debbie D Nahas, et al.
Page
of 4